一、职务、职称
职务：重庆大学附属肿瘤医院放射物理技术中心科研组组长
职称：高级工程师
二、学习经历：本科、硕士、博士
1. 2008.09−2013.06，中国科学技术大学，核科学技术，硕博，工学博士
2. 2004.09−2008.06，聊城大学，应用物理学，理学学士
三、工作经历
1. 2018.05−至今，重庆大学附属肿瘤医院，放疗科物理师，高级工程师
2. 2015.12−2018.05，重庆大学附属肿瘤医院，放疗科物理师，工程师
3. 2013.12−2015.12，重庆大学附属肿瘤医院，放疗科物理师，博士后工作站
4. 2013.06−2013.12，重庆大学附属肿瘤医院，放疗科物理师
四、研究方向
主要从事肿瘤放疗物理、加速器物理方面的研究。在肿瘤放疗物理领域，其主要研究方向为器官运动、计划质量控制、放疗流程自动化、自适应放疗等。
五、教学课程
曾参与《加速器物理》课程的教学工作。
六、成果：选取有代表性的
1.文章
(1).Xinhao Yu, Fu Jin,Huanli Luo, et al. Gross tumor volume segmentation for stage III NSCLC radiotherapy using 3D ResSE-Unet. Technology in Cancer Research & Treatment, 2022, 21:1-12.
(2).Shilin Wang, Wen Tang,Huanli Luo, et al. Efficacy and Toxicity of Whole Pelvic Radiotherapy Versus Prostate-only Radiotherapy in Localized Prostate Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology, 2022,11:796907.
(3).彭海燕,罗焕丽,梁宝中,等.肤色对表面光学系统引导放疗摆位的影响.中华放射肿瘤学杂志, 2021, 30 (12):1297-1303.
(4).Qicheng Li(共同第一),Huanli Luo(共同第一), Xianfeng Liu, et al. Evaluation of plan quality based on a novel plan difficulty index and its preliminary application in radiotherapy. Journal of Radiation Research and Applied Sciences, 2021, 14(1):477-485.
(5).Fu Jin, Qiang Liu,Huanli Luo, et al.Dynamic Changes in Bladder Morphology Over Time in Cervical Cancer Patients. Cancer Control, 2021, 28:1-8.
(6).李师,罗焕丽,谭霞,等. 6 MV光子束放射治疗中发泡胶的剂量学影响.中国医学物理学杂志, 2021, 38(4):397-403.
(7).李超,罗焕丽,靳富,等.直肠癌术前放疗剂量及其分割模式的研究进展.重庆医学, 2020, 49(19):3288-3292+3296.
(8).Xian Tan,Huanli Luo, Shi Li, et al. Preliminary Results on In-Vivo Dose Measurement of Intensity-Modulated Radiotherapy for Cervical Cancer. International Journal of Radiation OncologyžBiologyžPhysics, 2020, 108(3): E280.
(9).谭霞,罗焕丽,王颖,等.宫颈癌调强放疗在体剂量监测初步研究.中华放射肿瘤学杂志，2020, 29 (9): 784-789.
(10).Fu Jin(共同第一),Huanli Luo(共同第一), Juan Zhou, et al. Dose–time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer. Ther Adv Med Oncol, 2020, 12:1–20.
(11).Fu Jin, Juan Zhou,Huanli Luo, et al. The impacts of dose-time-fractionation schedules on pathological complete response rate (pCR) and local recurrence (LR). Annals of Oncology, 2019, 30(suppl_9): ix30-ix41.
(12).Huanli Luo, Fu Jin, Xianfeng Liu, et al. Dosimetric Evaluation and Second Primary Cancer Risk Prediction after Three-Dimensional Ultrasound-Guided Radiotherapy of Cervical Cancer. Int J Radiation Oncol Biol Phys, 2019, 105(1) Supplement: E743–E744.
(13).Qicheng Li,Huanli Luo, Haiyang Peng, et al. Plan Quality Evaluation and Preliminary Application of a Novel Plan Difficulty Index in Radiotherapy of Lung Cancer. Int J Radiation Oncol Biol Phys, 2019,105(1)Supplement: E743.
(14).Fu Jin,Huanli Luo, Juan Zhou, et al. Dynamic Changes in Bladder Morphology over Time in a Population–Based Female Sample. Int J Radiation Oncol Biol Phys, 2019, 105(1)Supplement: E742–E743.
(15).彭海燕,罗焕丽,毛开金,等.表面光学系统Catalyst在宫颈癌放疗中的临床应用,中华放射肿瘤学杂志, 2019.3, 28(3): 198-202.
(16).Huanli Luo, Yanan He, Fu Jin, et al. Impact of CT slice thickness on volume and dose evaluation during thoracic cancer radiotherapy. Cancer Management and Research, 2018:10 3679–3686.
(17).Fu Jin,Huan-Li Luo, Juan Zhou, et al. Cancer risk assessment in modern radiotherapy workflow with medical big data. Cancer Management and Research, 2018:10 1665–1675.
(18).He Yanan,Luo Huanli, Jin Fu, et al. Effects of computed tomography slice thickness on clinical target volume and dose in intensity-modulated radiotherapy for chest cancer based on different reconstruction methods. Chinese Journal of Medical Physics, 2018, 35(3):249-255.
(19).Luo Huanli, Peng Haiyan,Jin Fu, et al. Catalyst system in patient positioning during breast cancer radiotherapy:clinical application and influencing factors. Chinese Journal of Radiation Oncology, 2018, 27(2): 190-194.
(20).Fu Jin,Hunali Luo, Juan Zhou, et al.A parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy of cervical cancer. Scientific Reports, 2017, 7:280.
(21).Fu Jin, Juan Zhou,Huanli Luo, et al. COMMENTS: Lung Size and the Risk of Radiation Pneumonitis. Int J Radiation Oncol Biol Phys, 2016, 96(2):481-485.
(22).Huanli Luo, Fu Jin,Dingyi Yang, et al.Interfractional variation in bladder volume and its impact on cervical cancer radiotherapy: clinical significance of portable bladder scanner. Medical Physics 2016, 43(7):4412-4419.
(23).韦隽昊,罗焕丽,陈曲珊,等.紧凑型自由电子激光THz源上四极磁铁的设计及测量.强激光与粒子束, 2016, 28(11):115101.
(24).Wu Lihua, Wang Ying, Jin Fu, Yang Dingyi, Yin Li,Luo Huanli(通讯作者).. Application and importance of portable bladder scanner in cervical cancer radiotherapy. Chinese journal of medical physics, 2016, 33(7): 654-657.
(25).Xianlu Zhuo,Huanli Luo, Aoshuang Chang, et al. Is overexpression of TWIST, a transcriptional factor, a prognosticbiomarker of head and neck carcinoma? Evidence from fifteen studies. Scientific Reports, 2015, 5:18073.
(26).Wang Ying,Luo Huanli, Li Fang, et al. The comparison of bladderscan and ultrasound system on evaluating the bladder capacity. Anticancer Research: International Journal of Cancer Research and Treatment, 2015, 35(7):4300-4301.
(27).罗焕丽,靳富,王颖,等.肿瘤放疗中体外误差与体内误差的关联性.中国医学物理学杂志, 2016, 33(1):10-15.
(28).罗焕丽,王颖,李芳,等.便捷式膀胱容量测定仪BVI9400及超声系统iU22评估膀胱容量的对比研究.中国医疗器械杂志, 2015, 39(4):295-298.
(29).Huanli Luo, Yucun Xu, Xiangqi Wang, et al. Conception design of helium ion FFAG accelerator with induction accelerating cavity. Chinese Physics C, 2013, 37(9):097001.
(30).Xiangqi Wang,Huanli Luo, Hao Hao, et al. Design of proton beam optics to realize beam distribution transformation in C-ADS HTBT, Chinese Physics C, 2013, 37(2):027004.
2.专利
(1).一种调强放疗计划评估参数矩阵确定方法、装置及介质,CN114420252A(公开号),2022.04
(2).用于宫颈筛查的电阻抗检测系统, CN 109700459 B(授权号), 2022.02
(3).剂量传输指标综合计算软件V1.0,2022SR0178124(授权号), 2022.01
(4).束流通量指标计算软件V1.0,2022SR0178127(授权号), 2022.01
(5).精度指标综合计算服务软件V1.0,2022SR0178190(授权号), 2022.01
(6).计划复杂度指标计算结果呈现服务平台V1.0,2022SR0178126(授权号), 2022.01
(7).一种圆孔径反对称简化六极场磁铁装置及其制造方法,CN201310259701.2(授权号),2013.10.
(8).简化十二极场磁铁装置及其制造方法,CN201210334199.2(授权号), 2013.01.
3.项目
(1).国家自然科学基金青年科学基金项目,11805025,子宫颈癌自适应放疗中关于个体化自动计划优化及放疗毒性预测的相关研究,2019.01−2021.12 21万元,主持.
(2).重庆市自然科学基金面上项目,cstc2021jcyj-msxmX0441,放射治疗计划复杂度评估系统的关键技术研究与应用,2021-10−2024.09,10万,主持
(3).重庆市科委科研院所绩效激励引导专项,cstc2017jxjl130017,子宫颈癌精准调强放疗体内三维剂量重建方法的研究及临床评估,2018.01−2019.12,10万元,主持.
(4).重庆市卫健委面上项目,2015MSXM229,子宫颈癌旋转调强放疗膀胱体积动态监测模式建立及评估2015.9−2017.93万,主持.
(5).重庆市人社局博士后经费,Xm2014107,宫颈癌自适应放疗中实时算法的研究，2013.12−2015.12,5万,主持.
(6).国家自然科学基金面上项目,81972857,螺纹效应与旁观效应协同作用下的宫颈癌细胞损伤与组织代谢改变的研究,2020.01−2023.12,51万,第一主研.
(7).重庆市科卫联合项目重大项目,2022DBXM005,恶性肿瘤患者生理活动FACE放疗管理体系的研究与应用,2022.01−2026.12,100万,第二主研.
(8).重庆科委基础研究与前沿探索类项目,cstc2021ycjh-bgzxm0023,宫颈癌螺旋断层放疗中旁观效应的相关研究,2021.06−2024.06,40万,第二主研.
(9).重庆市科委科研院所绩效激励引导专项，基于表面光学系统的肺部肿瘤位置与呼吸运动关系的研究，2021.01−2022.12, 10万,第二主研.
(10).重庆市科委中央引导地方科技发展专项，三维超声引导宫颈癌放疗技术推广，2019.02−2020.02, 30万,第二主研.
(11).国家自然科学基金委面上项目,11575038,图像引导放疗中区域化剂量验证方法的研究,2016.01−2019.12,58万,第二主研.
(12).国家自然科学基金委员会主任基金,11045003,氦离子固定场交变梯度加速器概念设计研究,2011.01−2012.12,19万,第三主研.
(13).国家科技部重点研发计划项目,2018YFC1312104,《恶性肿瘤规范化早诊早治关键技术集成及应用体系建设研究》子课题《恶性肿瘤早期治疗新技术新方法的临床评价研究》,2018.01−2021.06,1108万元,第三主研.
4.获奖
(1).2017年度 重庆市科学技术委员会，科技进步奖·二等奖
(2).2017年度，肿瘤精准医学产品创新创业团队，重庆市创新创业示范团队
(3).2016年度，重庆市卫健委，科技进步奖·一等奖
